{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T05:19:02Z","timestamp":1732684742254,"version":"3.28.2"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaad.2023.05.068","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:56:14Z","timestamp":1685771774000},"page":"1153-1154","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter from the Editor: Drug reaction with eosinophilia and systemic symptoms syndrome"],"prefix":"10.1016","volume":"90","author":[{"given":"Dirk M.","family":"Elston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2023.05.068_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.jaad.2023.05.068_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2019.12.057","article-title":"The diagnostic criteria of DRESS syndrome must be addressed","volume":"82","author":"Heymann","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.05.068_bib3","doi-asserted-by":"crossref","unstructured":"Zhu H, Ren V. Immunopathogenic insights on preferential human herpesvirus-6 reactivation in drug rash with eosinophilia and systemic symptoms: a scoping review. Preprint. Posted online May 25, 2023. J Cutan Med Surg. https:\/\/doi.org\/10.1177\/12034754231177590","DOI":"10.1177\/12034754231177590"},{"key":"10.1016\/j.jaad.2023.05.068_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1134178","article-title":"Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"14","author":"Rubin","year":"2023","journal-title":"Front Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223010083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223010083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:23:47Z","timestamp":1732609427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223010083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0190962223010083"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.05.068","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter from the Editor: Drug reaction with eosinophilia and systemic symptoms syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.05.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.05.067","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}